Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

AIM ImmunoTech Inc. (AIM) vs COSCIENS Biopharma Inc. (CSCIF)

AIM ImmunoTech Inc. and COSCIENS Biopharma Inc. are both Biotechnology companies. AIM ImmunoTech Inc. and COSCIENS Biopharma Inc. are of similar size ($8.6M and $8.0M). AIM ImmunoTech Inc. has negative trailing earnings, so its P/E is not meaningful; COSCIENS Biopharma Inc. trades at 1.0×. COSCIENS Biopharma Inc. grew revenue faster over the last twelve months: −3.02% against −21.5%. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs −15,021.1%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 17 metrics below, COSCIENS Biopharma Inc. leads on 12 and AIM ImmunoTech Inc. on 5.

Valuation

Metric AIM CSCIF Biotechnology median
P/E n/m 0.97 7.88
P/S 34.24 0.73 11.47
P/B 0.42 0.43 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.65 n/m 0.74
EV/Sales (66.26) 0.13 10.73
Earnings yield (1,537.53%) 103.12% (28.84%)
Free cash flow yield (449.55%) (48.39%) (23.03%)

Profitability

Metric AIM CSCIF Biotechnology median
Gross margin (23.16%) 46.48% 65.16%
Operating margin (11,724.21%) (71.13%) 0.00%
Net margin (15,021.05%) 75.11% 0.00%
Free cash flow margin (15,385.26%) (40.36%) 0.00%
Return on equity (2,382.30%) 59.74% (57.72%)
Return on assets (169.28%) 28.24% (49.22%)
Return on invested capital 0.00% (40.56%) 0.00%

Growth

Metric AIM CSCIF Biotechnology median
Revenue growth (TTM) (21.49%) (3.02%) 5.64%
EPS growth (last fiscal year) 72.19% 44.86% —
Revenue growth, 5-year CAGR (11.60%) 15.47% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AIM CSCIF Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.11 4.33 4.73
Net debt to EBITDA 0.22 0.78 0.96

Dividend

Metric AIM CSCIF Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric AIM CSCIF Biotechnology median
Market cap 7.97m 8.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack